Kernal Biologics, Inc.

Kernal is creating mRNA therapies that instruct specific cells on how to make their own drugs to cure an illness. Today, we are targeting COVID-19 and cancer, but this technique can be used for a number of other illnesses, too. With roots at MIT, Harvard and Bio Pharma, the team previously built a successful Biotech company and has deep technical expertise in mRNA space.

Current Job Openings

R&D